Overview
SickKids and UHN have developed MedlyPeds which is a smart phone application designed to remotely monitor patients with heart disease. This is a feasibility study which will enroll up to 30 patients with different types of heart disease to see which patient types may benefit the most from MedlyPeds if it were to be used for clinical monitoring. The study is gathering feedback about the app from patients, parents and clinicians to confirm how it needs to be modified to better serve the purpose in a future trial.
Description
This is a prospective cohort study that will enroll up to 30 patients with various types of heart disease and up to 10 clinicians in the MedlyPeds program and follow the participants for 3 months. Quality of life questionnaires will be completed at baseline and 3 months or end of study. Patient participants will complete a questionnaire about MedlyPeds and their experience using the app at 3 month or end of study. A subset of patient participants and clinicians will be asked to complete an interview at the end of the study.
Eligibility
Inclusion Criteria:
- Consent provided.
- Aged 8-18 years of age.
- Ability to comply with using Medly (ex. able to stand on the weight scale, able to answer symptom questions, etc.)
- Followed at the Hospital for Sick Children Cardiology Clinic for any of the following reasons:
- Heart failure of any etiology
- Congenital heart disease
- Acquired heart disease (eg. Kawasaki disease, rheumatic heart disease, connective tissue disorders etc)
- Pulmonary hypertension
- Post-cardiac surgery including heart transplant and ventricular assist devices
Exclusion Criteria:
- Unable to read or write in English.
- Participating in another clinical trial that may confound the results.\ \Participant may be re-screened for eligibility at a later date.
